IRIS
VILLANI, ROSANNA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 2.527
NA - Nord America 1.579
AS - Asia 391
AF - Africa 8
Continente sconosciuto - Info sul continente non disponibili 6
SA - Sud America 3
Totale 4.514
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 1.576
IE - Irlanda 915
SE - Svezia 451
IT - Italia 448
UA - Ucraina 357
CN - Cina 249
FR - Francia 96
DE - Germania 71
SG - Singapore 71
FI - Finlandia 63
GB - Regno Unito 47
TR - Turchia 25
IN - India 23
PL - Polonia 19
AT - Austria 17
BE - Belgio 15
CZ - Repubblica Ceca 13
JP - Giappone 7
EG - Egitto 4
EU - Europa 4
IR - Iran 4
NL - Olanda 4
RO - Romania 4
A2 - ???statistics.table.value.countryCode.A2??? 2
BR - Brasile 2
CA - Canada 2
ET - Etiopia 2
HK - Hong Kong 2
HU - Ungheria 2
PH - Filippine 2
PK - Pakistan 2
RU - Federazione Russa 2
TW - Taiwan 2
ZA - Sudafrica 2
CH - Svizzera 1
CL - Cile 1
ES - Italia 1
KR - Corea 1
MO - Macao, regione amministrativa speciale della Cina 1
MX - Messico 1
SA - Arabia Saudita 1
SM - San Marino 1
VN - Vietnam 1
Totale 4.514
Salva come PNG Salva come JPEG
Città #
Dublin 913
Nyköping 313
Chandler 254
Jacksonville 217
Wilmington 113
Dearborn 103
Princeton 89
New York 58
Nanjing 57
Ann Arbor 51
Ashburn 51
Foggia 50
Helsinki 46
Singapore 45
Beijing 35
Rome 31
Nanchang 23
Des Moines 22
Bari 20
Kraków 18
San Mateo 18
Shenyang 18
Vienna 17
Kunming 16
Brussels 15
Hebei 14
Milan 14
Gravina In Puglia 13
San Severo 13
Stevenage 13
Boardman 11
Caserta 11
Hangzhou 11
Norwalk 11
Tianjin 11
Woodbridge 11
Brno 9
Houston 9
Orange 9
Seattle 9
Zhengzhou 9
Cagliari 8
Ariano Irpino 7
Changsha 7
Falls Church 7
Jiaxing 7
London 6
Nembro 6
Borås 5
Como 5
Martina Franca 5
Redwood City 5
San Giovanni Rotondo 5
Stockholm 5
Bologna 4
Brindisi 4
Castellana Grotte 4
Guangzhou 4
Jinan 4
Ningbo 4
Saint-Fons 4
Terracina 4
Tokyo 4
Turin 4
Avigliano 3
Barletta 3
Candiolo 3
Changchun 3
Dagenham 3
Fremont 3
Hilden 3
Los Angeles 3
Naples 3
Niedernberg 3
Olomouc 3
Parma 3
Pimonte 3
Saga 3
Saint Paul 3
San Jose 3
Shanghai 3
Taizhou 3
Washington 3
Acquaviva Delle Fonti 2
Addis Ababa 2
Atlanta 2
Bellville 2
Bitonto 2
Carpi 2
Cedar Knolls 2
Central 2
Cutrofiano 2
Dallas 2
Grumo Appula 2
Hefei 2
Izmir 2
Koenigswinter 2
Lahore 2
Las Vegas 2
Leawood 2
Totale 2.980
Salva come PNG Salva come JPEG
Nome #
Direct-acting antivirals (daas) increase the serum vegf level in patients with chronic hepatitis c: a rationale for tumor recurrence 220
Strategie per la gestione del paziente HBV+ in terapia con immunosoppressori 164
Ulcere da decubito, prevenzione e trattamento. 141
Liver toxicity induced by amiodarone is dependent on mitochondria Complex I impairment, OXPHOS uncoupling and cardiolipin peroxidation. 137
DAAs rapidly reduce inflammation but increase serum VEGF level: A rationale for tumor risk during anti-HCV treatment 100
Chronic psychosocial defeat differently affects lipid metabolism in liver and white adipose tissue and induces hepatic oxidative stress in mice fed a high-fat diet 100
To be or not to be: A two years surveillance for a CA 19-9 persistent elevation before cancer diagnosis and bone metastases 95
Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer’s Disease 93
DAAs increase serum VEGF level: a rationale for tumour risk recurrence during anti-HCV treatment 90
Transarterial chemoembolization vs bland embolization in hepatocellular carcinoma: A meta-analysis of randomized trials 81
Effects of dietary fatty acids and cholesterol excess on liver injury: a lipidomic approach 80
Analogs in the treatment of chronic hepatitis B: real life experience with tenofovir and entecavir 79
Mitochondrial Signaling and Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Implications 77
Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients with Circulating Cryoglobulins 75
Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis 74
Amiodarone induces liver toxicity by impairing liver mitochondria bioenergetics and redox balance. 73
Treatment of chronic HCV infection in the era of protease inhibitors 73
Biopsychosocial predictors of interferon-related depression in patients with Hepatitis C 71
Efficacy and safety of direct-acting antivirals in elderly with chronic hepatitis C: results from a retrospective cohort study 70
HOW OFTEN HAVE WE SAID: IF I HAD THOUGHT OF IT BEFORE? 69
Lipid metabolism in development and progression of hepatocellular carcinoma 66
Analysis of Outcomes in Ischemic vs Nonischemic Cardiomyopathy in Patients with Atrial Fibrillation: A Report from the GARFIELD-AF Registry 66
Two-year outcomes of patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF 64
Platelet count does not predict bleeding in cirrhotic patients: Results from the PRO-LIVER Study 64
Linking lipid peroxidation and neuropsychiatric disorders: focus on 4-hydroxy-2-nonenal 64
Vitamin K antagonist control in patients with atrial fibrillation in Asia compared with other regions of the world: Real-world data from the GARFIELD-AF registry 62
NAFLD fibrosis score identifies not only advanced liver fibrosis but also chronic vascular complications in type 2 diabetic patients 60
Characteristics of patients with atrial fibrillation prescribed antiplatelet monotherapy compared with those on anticoagulants: Insights from the GARFIELD-AF registry 58
Evolving antithrombotic treatment patterns for patients with newly diagnosed atrial fibrillation 56
Modulation of the oxidative stress and lipid peroxidation by endocannabinoids and their lipid analogues 56
Comparison of international normalized ratio audit parameters in patients enrolled in GARFIELD-AF and treated with vitamin K antagonists 56
Molecular Aspects and Treatment of Iron Deficiency in the Elderly 56
Oxysterols and redox signaling in the pathogenesis of non alcoholic fatty liver disease. 55
DIRECT-ACTING antivirals restore systemic redox homeostasis in chronic HCV patients 55
From Cannabis sativa to Cannabidiol: Promising Therapeutic Candidate for the Treatment of Neurodegenerative Diseases 55
Serum Albumin Is Inversely Associated With Portal Vein Thrombosis in Cirrhosis 54
Direct-acting antivirals improve kidney function in diabetic patients with HCV infection and chronic kidney disease 50
Quality of vitamin k antagonist control and 1-year outcomes in patients with atrial fibrillation: A global perspective from the GARFIELD-AF registry 49
Pharmacological treatment of depression in Alzheimer's disease: A challenging task 49
Inhibition of nuclear factor (erythroid-derived 2)-like 2 promotes hepatic progenitor cell activation and differentiation 49
Diagnostic reliability of the procalcitonin serum marker in septic frail patient 48
Risk factors for death, stroke, and bleeding in 28,628 patients from the GARFIELD-AF registry: Rationale for comprehensive management of atrial fibrillation 48
Stroke prevention, 1-year clinical outcomes and healthcare resource utilization in patients with atrial fibrillation in France: Data from the GARFIELD-AF registry 46
Portal vein thrombosis relevance on liver cirrhosis: Italian Venous Thrombotic Events Registry 46
Age, mitochondria and bladder cancer 44
In-hospital mortality and length of stay in cirrhotic patients with sepsis treated with non-selective beta-blockers 44
Liver fat content assessed by conventional B-mode ultrasound and metabolic profile in non-diabetic patients: Implications for clinical practice 43
Direct-acting antivirals improve kidney function in diabetic patients with HCV infection and chronic kidney disease 43
Immunity as cornerstone of non-alcoholic fatty liver disease: The contribution of oxidative stress in the disease progression 42
Asymptomatic saccular portal vein aneurysm: a case report and review of the literature 42
Direct-acting antivirals for HCV treatment in older patients: A systematic review and meta-analysis 41
Unmet clinical questions in elderly patients with locally advanced and metastatic bladder cancer 41
A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model 40
Molecular Aspects and Treatment of Iron Deficiency in the Elderly 40
Management of intermediate-stage hepatocellular carcinoma in the elderly with transcatheter arterial chemoembolization failure: Retreatment or switching to systemic therapy? 36
Temporal profile of SARS-CoV-2 viral load in posterior nasopharyngeal samples: Analysis of 944 patients in Apulia, Italy 34
High prevalence of false positive SARS-CoV2 serology in a cohort of patients with liver autoimmune diseases 33
Synergistic interaction of fatty acids and oxysterols impairs mitochondrial function and limits liver adaptation during nafld progression 33
THU-323-Impact of genetic polymorphisms associated with NAFLD on hepatic and vascular complications in diabetes 33
Genetic Polymorphisms and Clinical Features in Diabetic Patients With Fatty Liver: Results From a Single-Center Experience in Southern Italy 33
Effects of direct-acting antiviral agents on lipid and glucose profile in HCV patients with type 2 diabetes: A real-life Italian experience 32
Impact of gender on event rates at 1-year in patients with newly diagnosed non-valvular atrial fibrillation: Contemporary perspective from the GARFIELD-AF registry 32
INSULINEMIC RESPONSE CURVE AFTER ORAL GLUCOSE TOLERANCE TEST IDENTIFIES EARLY ALTERATIONS OF GLUCOSE METABOLISM IN PATIENTS AFFECTED BY CHRONIC LIVER DISEASE 32
Management and 1-year outcomes of patients with newly diagnosed atrial fibrillation and chronic kidney disease: Results from the prospective garfield-af registry 32
Risk of Statin-Induced Hypertransaminasemia: A Systematic Review and Meta-Analysis of Randomized Controlled Trials 32
US-GUIDED PROBE POSITIONING DOES NOT IMPROVE APPLICABILITY BUT REDUCES VARIABILITY IN LIVER STIFFNESS (FIBROSCAN) MEASUREMENT 31
Two-Dimensional Shear Wave Elastography Versus Transient Elastography: A Non-Invasive Comparison for the Assessment of Liver Fibrosis in Patients With Chronic Hepatitis C 31
The glucose metabolic pathway as a potential target for therapeutics: Crucial role of glycosylation in alzheimer’s disease 31
Predictors of NOAC versus VKA use for stroke prevention in patients with newly diagnosed atrial fibrillation: Results from GARFIELD-AF 30
Risk profiles and one-year outcomes of patients with newly diagnosed atrial fibrillation in India: Insights from the GARFIELD-AF Registry 30
NAFLD fibrosis score (NFS) can be used in outpatient services to identify chronic vascular complications besides advanced liver fibrosis in type 2 diabetes 30
Management of intermediate-stage hepatocellular carcinoma in the elderly with transcatheter arterial chemoembolization failure: Retreatment or switching to systemic therapy? 30
Stroke prevention in patients from Latin American countries with non-valvular atrial fibrillation: Insights from the GARFIELD-AF registry 29
Impact of genetic polymorphisms associated with NAFLD on hepatic and vascular complications in diabetes 29
Impatto della terapia con Peg-interferone o entecavir sulla fibrosi epatica mediante elastomeri: osservazione dopo 4 anni 29
The dual role of glutamatergic neurotransmission in Alzheimer’s disease: From pathophysiology to pharmacotherapy 29
Assessing the impact of COVID-19 on liver cancer management (CERO-19) 29
The GLP-1 receptor agonist Exendin-4 modulates hippocampal NMDA-receptor signalling in aged rats and improves cognitive impairment in diabetic elderly patients 28
Serum lipid profile in HCV patients treated with direct-acting antivirals: a systematic review and meta-analysis 28
Molecular mechanisms involved in HCC recurrence after direct-acting antiviral therapy 27
Prevalence and risk factors for hospital-acquired anemia in internal medicine patients: learning from the "less is more" perspective 26
The effect of direct-acting antivirals on hepatocellular carcinoma recurrence: still waiting for the turning point 26
Liver fibrosis by FibroScan is highly prevalent in type 2 diabetic patients with NAFLD and fairly normal liver enzymes but increased uric acid 26
NAFLD fibrosis score identifies not only advanced liver fibrosis but also chronic vascular complications in type 2 diabetic patients 26
Lipid metabolism in development and progression of hepatocellular carcinoma 26
Improved risk stratification of patients with atrial fibrillation: An integrated GARFIELD-AF tool for the prediction of mortality, stroke and bleed in patients with and without anticoagulation 24
Autoimmune liver disease and multiple sclerosis: state of the art and future perspectives 24
Effects of Ultramicronized Palmitoylethanolamide on Mitochondrial Bioenergetics, Cerebral Metabolism, and Glutamatergic Transmission: An Integrated Approach in a Triple Transgenic Mouse Model of Alzheimer's Disease 24
Liver fibrosis by FibroScan® independently of established cardiovascular risk parameters associates with macrovascular and microvascular complications in patients with type 2 diabetes 23
Robot-assisted pelvic lymphadenectomy for prostate cancer. Potentially advantageous in the elderly? 23
Tocilizumab and liver injury in patients with COVID-19 23
Pharmacological and toxicological effects of phytocannabinoids and recreational synthetic cannabinoids: Increasing risk of public health 21
Hepatocellular carcinoma recurrence after direct-acting antiviral therapy: An individual patient data meta-analysis 20
Lenvatinib versus sorafenib as first-line therapy of advanced hepatocellular carcinoma: a systematic review and meta-analysis 17
null 17
Incidence and Recurrence of Portal Vein Thrombosis in Cirrhotic Patients 15
Metabolic reprogramming in inflammatory microglia indicates a potential way of targeting inflammation in Alzheimer's disease 14
Eradication of HCV by direct antiviral agents restores mitochondrial function and energy homeostasis in peripheral blood mononuclear cells 8
Liver Ultrasound Elastography in Non-Alcoholic Fatty Liver Disease: A State-of-the-Art Summary 7
Exploring the Relationship between Epicardial Fat Thickness and Coronary Revascularization: Implications for Cardiovascular Health 6
Totale 4.913
Salva come PNG Salva come JPEG
Categoria #
all - tutte 29.543
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 29.543
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/201943 0 0 0 0 0 0 0 0 0 0 0 43
2019/2020553 82 51 29 8 68 75 71 16 44 9 45 55
2020/2021756 92 8 75 25 75 24 81 119 119 87 13 38
2021/2022553 28 11 17 10 44 35 38 39 88 93 28 122
2022/20231.996 209 86 91 51 86 161 28 154 1.022 19 50 39
2023/2024432 56 46 16 20 28 94 17 31 7 4 9 104
Totale 4.926